Home Cart Sign in  
Chemical Structure| 852475-26-4 Chemical Structure| 852475-26-4

Structure of MC1568
CAS No.: 852475-26-4

Chemical Structure| 852475-26-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MC1568 is a selective inhibitor of class II (IIa) histone deacetylas (HDAC II) with IC50 of 220 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MC1568

CAS No. :852475-26-4
Formula : C17H15FN2O3
M.W : 314.31
SMILES Code : O=C(NO)/C=C/C1=CC=C(/C=C/C(C2=CC=CC(F)=C2)=O)N1C
MDL No. :N/A
InChI Key :QRDAPCMJAOQZSU-KQQUZDAGSA-N
Pubchem ID :11381449

Safety of MC1568

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319
Precautionary Statements:P305+P351+P338

Related Pathways of MC1568

epigenetics

Isoform Comparison

Biological Activity

Target
  • HD1

    HD1-B (Maize), IC50:3.4 μM

    HD1-A (Maize), IC50:100 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
PAECs 1 μM 24 hours MC1568 significantly increased the expression of miR-424, miR-503, Cx37, Cx40, and KLF2, and significantly reduced the proliferation and migration of PAH PAECs. PMC4293354
INS-1 832/13 beta cells 1 μmol/l 24 hours MC1568 restored glucose-stimulated insulin secretion (GSIS) in Hdac7-overexpressing cells but had no effect on control cells. PMC6518079
C2C12 cells 5 µM 48 hours MC1568 inhibits muscle differentiation by stabilizing the HDAC4–HDAC3–MEF2D complex and inhibiting MEF2D acetylation. PMC2693879
pancreatic explants 10 µmol/L 14 days MC1568 enhanced the expression of Pax4 and amplified the pool of endocrine β- and δ-cells. PMC3198089
Jurkat T-cells 1 µM to 100 µM 24 hours To evaluate the cytotoxicity and ability of MC1568 to enhance Tax expression in Jurkat T-cells, results showed that MC1568 treatment had minimal impact on cell viability and did not significantly enhance Tax expression. PMC9424546

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
rats MCT and SUGEN models intraperitoneal injection 100 µL of 300 mM Single injection, duration of 70 minutes MC1568 significantly reduced right ventricular systolic pressure (RVSP) in both MCT and SUGEN models, decreased the right ventricle to left ventricle plus septum weight ratio (RV/LV+S), and significantly reduced the muscularization of pulmonary arterioles. PMC4293354
Rats Cocaine self-administration model Intraperitoneal injection 43 mg/kg daily for 4 weeks MC1568 enhances compulsive cocaine self-administration by promoting nuclear degradation of HDAC4 and HDAC5. PMC5665598
Mice WT and mdx mice Intraperitoneal injection 0.5 mg/kg Once daily for 10 days Treatment with MC1568 caused Cx43 to dissociate from gap junctions and distribute along the long axis of ventricular cardiomyocytes, suggesting that class IIa HDACs may play a role in stabilizing Cx43 localization to gap junctions or ICDs. PMC3041095
CD1 mice CD1 mice 40 mg/kg daily for 3 days MC1568 inhibits the activity of HDAC4 and HDAC5 in skeletal muscle and heart without affecting HDAC3 activity, thereby leaving MEF2–HDAC complexes in a repressed state. PMC2693879

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.18mL

0.64mL

0.32mL

15.91mL

3.18mL

1.59mL

31.82mL

6.36mL

3.18mL

References

 

Historical Records

Categories